Unique ID issued by UMIN | UMIN000007887 |
---|---|
Receipt number | R000009289 |
Scientific Title | An Exploratory study on safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy |
Date of disclosure of the study information | 2012/05/08 |
Last modified on | 2015/06/07 01:12:36 |
An Exploratory study on safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy
Safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy(ALCT002)
An Exploratory study on safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy
Safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy(ALCT002)
Japan |
Lung cancer patients planned to receive two or more cycles of cisplatin chemotherapy
Pneumology |
Malignancy
NO
To evaluate the safety of hydration using oral rehydration solution in comparison with the hydration using intravenous solution during cisplatin chemotherapy
Safety
serum creatinine
serum cystatinC
serum beta2-microglobulin
serum BUN
urine volume
urine sodium
urine NAG
urine beta2-microglobulin
creatinine clearance
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Food |
hydration using intravenous solution
(chemotherapy days 2 and 3)
Hydration using oral rehydration solution
(chemotherapy days 2 and 3)
20 | years-old | <= |
75 | years-old | > |
Male and Female
1. Patients with histologically or cytrologically confirmed diagnosis of lung cancer
2. Patients planned to receive two or more cycles of cisplatin chemotherapy
3. Patients aged between 20 and 74 years
4. Patients with ECOG Performance status of 0 to 2
5. Patients expected to survive longer than at least three months
6. Patients who can be treated after hospitalization
7. Patients who provide written informed consent
8. Patients who have never been treated with cisplatin previously
1. Patients with the serum creatinine level exceeding the upper limit of the hospital or with the estimated Ccr of 60mL/min or lower
2. Patients with intractable ascites or pleural effusion except those who have been treated by pleurodesis.
3. Patients with psychiatric disease or psychological symptom
4. Female patients of childbearing potential, pregnancy, or lactation
5. Patients with poorly controlled diabetes
6. Patients who meet the criteria specified in "contraindication" or "careful administration" in the package inserts of the intravenous solutions used in the study
7. Patients with difficulty eating or with grade 2 or higher anorexia (CTCAE 4.0)
8. Patients otherwise deemed unsuitable for inclusion in the study for any other reason based on the assessment by the investigator
60
1st name | |
Middle name | |
Last name | Takuma Yokoyama |
Kyorin Univercity Hospital
Department of Respiratory Medicine
6-20-2 shinkawa,Mitaka city,Tokyo
0422-47-5511
taku@ks.kyorin-u.ac.jp
1st name | |
Middle name | |
Last name | Takuma Yokoyama |
Kyorin Univercity Hospital
Department of Respiratory Medicine
6-20-2 shinkawa,Mitaka city,Tokyo
0422-47-5511
taku@ks.kyorin-u.ac.jp
Department of Respiratory Medicine
Kyorin Univercity Hospital
none
Other
NO
2012 | Year | 05 | Month | 08 | Day |
Unpublished
Completed
2012 | Year | 02 | Month | 17 | Day |
2012 | Year | 05 | Month | 01 | Day |
2014 | Year | 04 | Month | 30 | Day |
2014 | Year | 04 | Month | 30 | Day |
2014 | Year | 04 | Month | 30 | Day |
2015 | Year | 12 | Month | 31 | Day |
2012 | Year | 05 | Month | 03 | Day |
2015 | Year | 06 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009289
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |